Reeve Emma bought PTCT
January 5, 2026 · Form 4 insider transaction
Reeve Emma bought 734 shares of PTC Therapeutics, Inc. at $46.54 per share, a transaction worth $34.2K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
734
Price
$46.54
Total value
$34.2K
InsiderReeve Emma
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJanuary 5, 2026
Filing dateJanuary 6, 2026
Shares owned after11,400
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on March 4, 2025.